Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

"We are pleased to welcome Eric as Calidi's new CEO, given his deep experience in life science leadership with a focus on oncology, as Calidi advances its systemic enveloped virotherapy platform to ...

Representative Thomas Romeo Quioh of Sinoe County’s Electoral District-1 has admitted his connection to a shady logging ...

Additionally, Ajit Singh, M.S., Ph.D., will join Harbinger's Board of Directors. Dr. Singh is a partner at Artiman Ventures with extensive expertise leading and advising healthcare organizations ...

Hundreds of pages of documents describing the Legacy deal, and interviews with health care experts and OHSU insiders, reveal ...

Senate Democratic Leader Chuck Schumer says “Pete Hegseth must be fired” after reports that the defense secretary created another Signal messaging chat to share military air strike details. But White ...

Endocrine diseases pose significant health challenges, often contributing to premature morbidity and mortality. Traditional Randomized Controlled Trials ...

After much volatility because of Trump's trade war, the stock markets responded positively to a softened tone toward both ...

The Anti-Defamation League has called on a local California school board to apologize after two of its members attacked the Jewish community in comments at a meeting last week. The controversy is ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...